The GLP-1 Revolution: How Ozempic and Mounjaro are Reshaping India’s Body Positivity Landscape

The GLP-1 Revolution: How Ozempic and Mounjaro are Reshaping India’s Body Positivity Landscape

Pharmaceutical giants and medical practitioners across India are reporting a surge in demand for GLP-1 receptor agonists like Ozempic and Mounjaro as of late 2024, fundamentally shifting the national discourse on obesity from a lifestyle choice to a chronic metabolic disease. This pharmaceutical boom is sparking a complex debate among healthcare providers, activists, and the…

Read More